Introduction
Understanding Semaglutide and Modern Weight Loss
Understanding semaglutide for modern weight loss starts with what it is: a GLP-1 receptor agonist, first used for type 2 diabetes and now FDA-approved at 2.4 mg weekly (Wegovy) for chronic weight management. It acts on the hormone signals that regulate appetite, blood sugar and fullness after eating.
This guide explains how semaglutide works, who tends to benefit, what side effects to watch for, and why it is best used under real medical supervision. At Protocol Health in Scarsdale, NY, we see patients in person from across Westchester and by telehealth in New York, New Jersey, Connecticut, Florida and California, with individualized, lab-informed care rather than a one-size-fits-all prescription. This page covers semaglutide alone; for the GLP-1 class as a whole see GLP-1s for weight loss, and for how it compares with other peptides marketed for weight loss see the best peptides for weight loss.
Explore Physician-Led Semaglutide CareQuick Answer
What Is Semaglutide, in Plain Terms?
In plain terms, semaglutide is a once-weekly injectable medication that mimics GLP-1, a natural gut hormone that signals fullness to the brain and slows how quickly the stomach empties. For many patients, the result is reduced appetite, fewer cravings, and smaller portions that feel satisfying.
When combined with nutrition and lifestyle changes, research suggests semaglutide may support meaningful weight loss in many people who are candidates, though individual results vary. It is prescribed and monitored by a licensed provider, and suitability is determined case by case.
It is not a shortcut or a standalone fix. It tends to work best as one part of a supervised program that includes labs, follow-up, and attention to muscle, nutrition, and long-term habits.
The Science
How Does Semaglutide Work for Weight Loss?
Semaglutide works for weight loss by activating GLP-1 receptors found in the brain, gut, and pancreas. In the brain, this can dampen appetite and food-related cravings. In the stomach, it slows gastric emptying so you may feel full longer after meals.
It also supports healthier blood sugar regulation by prompting the pancreas to release insulin when glucose is elevated. This dual effect on appetite and metabolism is why the medication has been studied so extensively for both weight and metabolic health.
Because these effects build gradually, providers typically start at a low dose and increase slowly over several weeks. This titration approach helps the body adjust and can reduce the chance of significant side effects. In short, semaglutide supports weight loss by curbing appetite, slowing digestion and steadying blood sugar.
The Benefits
What Can Semaglutide Help With?
Semaglutide can help with weight reduction, its most recognized benefit. In many patients, semaglutide can help ease the frustrating plateau where diet and exercise alone stop producing results, largely by making appetite easier to manage.
Beyond the scale, STEP 1 participants on semaglutide had greater improvements in cardiometabolic risk factors and in self-reported physical functioning than those on placebo. In the separate SELECT trial of people with existing heart disease and no diabetes, semaglutide 2.4 mg lowered the rate of cardiovascular death, heart attack or stroke from 8.0% to 6.5% over about 40 months (Lincoff et al., 2023).
Semaglutide is one of two main options. In the SURMOUNT-5 head-to-head trial, tirzepatide produced more average weight loss than semaglutide over 72 weeks (20.2% vs 13.7%), so a provider may discuss tirzepatide as an alternative within an individualized plan. Either way, semaglutide helps most with weight and appetite, with cardiometabolic gains seen in trials.
The evidence
How much weight do people lose on semaglutide?
The best data on semaglutide for weight loss come from the STEP trials of the brand-name 2.4 mg weekly dose. In STEP 1, 1,961 adults with obesity or overweight and no diabetes were randomized to semaglutide or placebo, both alongside a lifestyle program. After 68 weeks, the semaglutide group lost an average of 14.9% of body weight, compared with 2.4% on placebo.
Averages hide a wide spread. In the same trial, 86.4% of people on semaglutide lost at least 5% of their weight, 69.1% lost at least 10%, and about half lost 15% or more. Some people lose much less. Your own response depends on starting weight, dose tolerance, sleep, protein intake, other medications and how consistently the drug is taken.
| STEP 1 outcome at 68 weeks | Semaglutide 2.4 mg | Placebo |
|---|---|---|
| Average change in body weight | -14.9% | -2.4% |
| Lost 5% or more | 86.4% | 31.5% |
| Lost 10% or more | 69.1% | 12.0% |
| Lost 15% or more | 50.5% | 4.9% |
Those numbers describe the FDA-approved brand product under trial conditions. Compounded semaglutide is not FDA-approved, is not the same as the brand-name product, and was not studied in the STEP trials, so the trial results do not transfer to it. Read our guide to compounded vs brand-name GLP-1s before choosing.
Candidacy
Who Is a Good Candidate for Semaglutide?
A good candidate for semaglutide is generally an adult with an elevated body mass index, or with weight-related health concerns, who has not reached their goals through lifestyle change alone. Candidacy is always determined individually by a provider after reviewing your history and labs.
It is not appropriate for everyone. People with certain thyroid or pancreatic histories, specific gastrointestinal conditions, or those who are pregnant or planning pregnancy are typically not candidates, which is why a thorough medical evaluation matters.
The best way to know if semaglutide fits your situation is a consultation. Many patients begin with a metabolic and weight-focused assessment so the plan reflects their real physiology, not a generic protocol.
Safety
What Are the Side Effects and Safety Considerations?
The most common side effects are gastrointestinal: nausea, mild digestive upset, constipation, or occasional heartburn, especially early in treatment or after a dose increase. For most patients these are temporary and ease as the body adjusts.
Slow, careful dose titration along with good hydration and nutrition can help minimize discomfort. More serious reactions are uncommon but real, which is why ongoing provider supervision and clear guidance on warning signs are essential rather than optional.
Semaglutide carries a boxed warning for thyroid C-cell tumors, based on rodent studies, and is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Pancreatitis, gallbladder problems and low blood sugar when combined with certain diabetes medications are among the less common risks your provider will review.
This information is educational and not medical advice. A qualified provider should review your full history, discuss risks, and monitor your response over time. Protecting lean muscle through adequate protein and activity is also an important part of safe, durable results.
The Experience
What Should You Expect Starting Treatment?
When starting treatment, you should expect an evaluation and baseline labs first so your provider understands your metabolic starting point. From there, you begin at a low dose administered as a simple once-weekly injection you can do at home.
Over the following weeks, your dose is gradually increased based on how you respond to and tolerate the medication. Regular check-ins let your provider adjust the plan, address side effects, and keep progress on track.
Weight change is typically gradual and steady rather than sudden. The patients who do best pair the medication with realistic nutrition, resistance training, and consistent follow-up, treating it as a supported process rather than a quick fix.
After treatment
What happens when you stop semaglutide?
Weight usually comes back when semaglutide is stopped, because the appetite signals it was quieting return. The STEP 4 trial tested this directly. After 20 weeks on semaglutide, 803 adults were randomized to keep taking it or switch to placebo. Over the next 48 weeks, those who continued lost a further 7.9% of body weight, while those switched to placebo regained 6.9%.
That result reframes semaglutide for weight loss as a long-term treatment for a chronic condition rather than a short course. It also explains why Protocol Health's medical weight loss program builds protein intake, resistance training and a maintenance plan into care from the start. If you and your physician decide to taper or stop, those habits are what you keep.
Muscle matters here too. Across GLP-1 trials, lean mass made up anywhere from about 15% to 40–60% of the weight lost (Neeland et al., 2024), which is why we track body composition rather than the scale alone. Our guide to GLP-1 muscle loss covers how to protect it.
Our Approach
The Protocol Health Approach to Semaglutide
Protocol Health is a family-owned, physician-led clinic in Scarsdale, NY, seeing patients in person from across Westchester and by telehealth in New York, New Jersey, Connecticut, Florida and California. Our weight-loss care is individualized, lab-informed, and delivered by a real clinical team.
We treat semaglutide as one tool inside a complete metabolic strategy. That means baseline labs, attention to hormones and muscle, honest conversations about candidacy, and ongoing follow-up rather than an anonymous prescription sent to your door.
If you are considering GLP-1 therapy, the first step is a conversation with a provider who can tailor the approach to you. Our goal is durable, healthy results you can maintain, supported by clinical depth at every stage.
FAQ
Frequently Asked Questions
How much weight can you lose on semaglutide?
In the STEP 1 trial, adults without diabetes on brand-name semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks, versus 2.4% on placebo, and about half lost 15% or more. Those are trial averages with lifestyle support; individual results vary and are never guaranteed.
Can you take semaglutide for weight loss without diabetes?
Yes. The STEP 1 trial enrolled adults with obesity or overweight who did not have diabetes, and brand-name semaglutide 2.4 mg is FDA-approved for chronic weight management in that group. Eligibility still depends on your BMI, weight-related conditions and medical history, which a provider reviews before prescribing.
Is semaglutide safe for long-term use?
Semaglutide has been studied in large trials, including SELECT, which followed people on it for about three years on average. Safety depends on your individual history, ongoing monitoring, and how you tolerate the medication. A qualified provider should evaluate whether continued use is right for you.
How is semaglutide taken?
It is most commonly given as a once-weekly injection under the skin, which patients can administer at home after guidance. Providers typically start at a low dose and increase gradually over several weeks to improve tolerability.
What is the difference between semaglutide and tirzepatide?
Semaglutide targets the GLP-1 receptor, while tirzepatide targets both GLP-1 and GIP. In the SURMOUNT-5 head-to-head trial, tirzepatide produced more average weight loss (20.2% vs 13.7% at 72 weeks); semaglutide has the SELECT cardiovascular outcomes trial in people without diabetes. A provider can help decide which fits you.
Do you regain weight after stopping semaglutide?
Most people regain weight after stopping. In the STEP 4 trial, people switched to placebo regained 6.9% of body weight over 48 weeks, while those who stayed on semaglutide lost a further 7.9%. A maintenance plan built with your provider, with protein and strength training in place, makes regain less likely.
Can I get semaglutide through telehealth?
Yes. Protocol Health offers physician-led telehealth in New York, New Jersey, Connecticut, Florida and California, along with in-person care in Scarsdale. Treatment still requires a medical evaluation and appropriate labs to confirm you are a candidate.
Explore